Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share (Details) - Schedule of Common Stock Equivalents

v3.24.0.1
Loss Per Share (Details) - Schedule of Common Stock Equivalents - shares
 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 12,556,512 12,600,328
Convertible Notes [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 9,341,825 9,341,825
Options [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 3,214,687 3,217,400
Warrants [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 41,103